BeStock  
Stocks › Biotechnology › ALNY

Alnylam Pharmaceuticals ALNY

US equityMarket cap rank #427Biotechnology
$236.54 −$10.20 (-4.13%)
Market open · Oct 1, 1:20 pm ET · After hours $246.74 0.00%
Open$248.21
Prev close$246.74
Day range$233.53 – $251.71
Volume868.2K
Market cap$31.65B
P/E (TTM)41.2
Dividend yield–

ALNY Stock News

Headlines matching Alnylam Pharmaceuticals or the ALNY ticker, most recent first.

  • Cantor Fitzgerald Maintains Alnylam Pharmaceuticals(ALNY.US) With Hold Rating, Cuts Target Price to $325Market news · 30 Sep 2026
  • J.P. Morgan Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Cuts Target Price to $369Market news · 30 Sep 2026
  • Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)TipRanks · 30 Sep 2026
  • Bernstein Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $376Market news · 26 Sep 2026
  • H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $455Market news · 21 Sep 2026
  • Needham Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $357Market news · 18 Sep 2026
  • Truist Financial Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy RatingMarket news · 18 Sep 2026
  • BMO Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $318Market news · 18 Sep 2026
  • Morgan Stanley Maintains Alnylam Pharmaceuticals(ALNY.US) With Hold Rating, Maintains Target Price $300Market news · 13 Sep 2026
  • Barclays Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $450Market news · 1 Sep 2026
  • A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $318 to $489Market news · 1 Sep 2026
  • Evercore Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Cuts Target Price to $325Market news · 6 Aug 2026
  • A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $315 to $455Market news · 5 Aug 2026
  • J.P. Morgan Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $375Market news · 5 Aug 2026
  • CCORF Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $429Market news · 3 Aug 2026

Discussion

No comments yet — be the first to weigh in on ALNY.

Leave a comment

Scroll to Top